Patents by Inventor Cherylle Goebel

Cherylle Goebel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PLASMA BASED PROTEIN PROFILING FOR EARLY STAGE LUNG CANCER DIAGNOSIS
    Publication number: 20240087754
    Abstract: The invention provides biomarkers and combinations of biomarkers useful in diagnosing non-small cell lung cancer. Measurements of these biomarkers are inputted into a classification system such as Random Forest to assist in determining the likelihood that an individual has non-small cell lung cancer. Kits comprising agents for detecting the biomarkers and combination of biomarkers, as well as systems that assist in diagnosing non-small cell lung cancer are also provided.
    Type: Application
    Filed: August 15, 2023
    Publication date: March 14, 2024
    Inventors: Cherylle Goebel, Christopher LOUDEN, Thomas C. LONG
  • Plasma based protein profiling for early stage lung cancer diagnosis
    Patent number: 11769596
    Abstract: The invention provides biomarkers and combinations of biomarkers useful in diagnosing non-small cell lung cancer. Measurements of these biomarkers are inputted into a classification system such as Random Forest to assist in determining the likelihood that an individual has non-small cell lung cancer. Kits comprising agents for detecting the biomarkers and combination of biomarkers, as well as systems that assist in diagnosing non-small cell lung cancer are also provided.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: September 26, 2023
    Assignee: LUNG CANCER PROTEOMICS LLC
    Inventors: Cherylle Goebel, Christopher Louden, Thomas C Long
  • PLASMA BASED PROTEIN PROFILING FOR EARLY STAGE LUNG CANCER PROGNOSIS
    Publication number: 20190221316
    Abstract: The invention provides biomarkers and combinations of biomarkers useful in diagnosing non-small cell lung cancer. Measurements of these biomarkers are inputted into a classification system such as Random. Forest to assist in determining the likelihood that an individual has non-small cell lung cancer. Kits comprising agents for detecting the biomarkers and combination of biomarkers, as well as systems that assist in diagnosing non-small cell lung cancer are also provided.
    Type: Application
    Filed: December 4, 2018
    Publication date: July 18, 2019
    Inventors: Cherylle Goebel, Christopher Louden, Thomas C Long